Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsR&D In ProcessShares IssuedShares OutstandingShares Outstanding
Ratios

Zenas BioPharma (ZBIO) Other Gross PP&E Adjustments (2023 - 2025)

Zenas BioPharma has reported Other Gross PP&E Adjustments over the past 3 years, most recently at -$11.4 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at -$11.4 million for Q4 2025, down 126.51% from a year ago — trailing twelve months through Dec 2025 was -$11.4 million (down 126.51% YoY), and the annual figure for FY2025 was -$11.4 million, down 126.51%.
  • Other Gross PP&E Adjustments for Q4 2025 was -$11.4 million at Zenas BioPharma, down from -$2.7 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for ZBIO hit a ceiling of -$2.0 million in Q2 2025 and a floor of -$11.4 million in Q4 2025.
  • Median Other Gross PP&E Adjustments over the past 3 years was -$2.7 million (2025), compared with a mean of -$4.1 million.
  • Peak annual rise in Other Gross PP&E Adjustments hit 15.5% in 2025, while the deepest fall reached 126.51% in 2025.
  • Zenas BioPharma's Other Gross PP&E Adjustments stood at -$3.2 million in 2023, then crashed by 56.88% to -$5.0 million in 2024, then plummeted by 126.51% to -$11.4 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$11.4 million (Q4 2025), -$2.7 million (Q3 2025), and -$2.0 million (Q2 2025) per Business Quant data.